bioAffinity Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIAF research report →
About the company
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer.
- CEO
- Maria Zannes
- IPO
- 2022
- Employees
- 57
- HQ
- San Antonio, TX, US
Price Chart
- Market Cap
- $3.76M
- P/E
- -0.23
- P/S
- 0.66
- P/B
- 1.02
- EV/EBITDA
- -0.13
- Div Yield
- 0.00%
- Gross Margin
- 22.14%
- Op Margin
- -204.29%
- Net Margin
- -280.57%
- ROE
- -358.76%
- ROIC
- -229.23%
- Revenue
- $6.16M · -34.18%
- Net Income
- $-14,909,754 · -64.93%
- EPS
- $-8.66 · 61.51%
- Op Income
- $-10,572,508
- FCF YoY
- -27.85%
- 52W High
- $13.50
- 52W Low
- $0.69
- 50D MA
- $1.63
- 200D MA
- $2.03
- Beta
- -1.11
- Avg Volume
- 444.23K
Get TickerSpark's AI analysis on BIAF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 12, 25 | Rios Roberto | other | 0 |
| Aug 12, 25 | Oppenheimer John J. | other | 0 |
| Jan 10, 25 | Reveles Xavier Trinidad | other | 21,604 |
| Jan 10, 25 | GIRGENTI STEVEN | other | 14,814 |
| Jan 10, 25 | Zannes Maria | other | 37,037 |
| Jan 10, 25 | Edwards James Michael | other | 6,172 |
| Jan 10, 25 | Zannes Timothy P | other | 8,641 |
| Nov 5, 24 | Edwards James Michael | other | 100,000 |
| Sep 16, 24 | Edwards James Michael | other | 0 |
| Sep 1, 22 | Edwards James Michael | other | 5,876 |
Our BIAF coverage
Recent articles, reports, and earnings notes.
No research on BIAF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIAF report →Similar companies
Peers in the same neighborhood.